Literature DB >> 34151592

FGF21 prevents low-protein diet-induced renal inflammation in aged mice.

Han Fang1, Sujoy Ghosh2,3, Landon C Sims1, Kirsten P Stone1, Cristal M Hill4, Denisha Spires5, Daria V Ilatovskaya5, Christopher D Morrison4, Thomas W Gettys1, Krisztian Stadler6.   

Abstract

Low-protein (LP) diets extend lifespan through a comprehensive improvement in metabolic health across multiple tissues and organs. Many of these metabolic responses to protein restriction are secondary to transcriptional activation and release of FGF21 from the liver. However, the effects of an LP diet on the kidney in the context of aging has not been examined. Therefore, the goal of the current study was to investigate the impact of chronic consumption of an LP diet on the kidney in aging mice lacking FGF21. Wild-type (WT; C57BL/6J) and FGF21 knockout (KO) mice were fed a normal protein diet (20% casein) or an LP (5% casein) diet ad libitum from 3 to 22 mo of age. The LP diet led to a decrease in kidney weight and urinary albumin-to-creatinine ratio in both WT and FGF21 KO mice. Although the LP diet produced only mild fibrosis and infiltration of leukocytes in WT kidneys, the effects were significantly exacerbated by the absence of FGF21. Accordingly, transcriptomic analysis showed that inflammation-related pathways were significantly enriched and upregulated in response to LP diet in FGF21 KO mice but not WT mice. Collectively, these data demonstrate that the LP diet negatively affected the kidney during aging, but in the absence of FGF21, the LP diet-induced renal damage and inflammation were significantly worse, indicating a protective role of FGF21 in the kidney.NEW & NOTEWORTHY Long-term protein restriction is not advantageous for an otherwise healthy, aging kidney, as it facilitates the development of renal tubular injury and inflammatory cell infiltration. We provide evidence using FGF21 knockout animals that FGF21 is essential to counteract the renal injury and inflammation during aging on a low-protein diet.

Entities:  

Keywords:  FGF21; aging; inflammation; kidney; low-protein diet

Mesh:

Substances:

Year:  2021        PMID: 34151592      PMCID: PMC8530754          DOI: 10.1152/ajprenal.00107.2021

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  51 in total

Review 1.  Potential health hazards of eating red meat.

Authors:  A Wolk
Journal:  J Intern Med       Date:  2016-09-06       Impact factor: 8.989

2.  Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.

Authors:  Seung Hyeok Han; Sung Hee Choi; Bong Jun Cho; Yenna Lee; Soo Lim; Young Joo Park; Min Kyung Moon; Hong Kyu Lee; Shin-Wook Kang; Dae Suk Han; Young-Bum Kim; Hak C Jang; Kyong Soo Park
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

3.  Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.

Authors:  H W Kim; J E Lee; J J Cha; Y Y Hyun; J E Kim; M H Lee; H K Song; D H Nam; J Y Han; S Y Han; K H Han; Y S Kang; D R Cha
Journal:  Endocrinology       Date:  2013-07-03       Impact factor: 4.736

4.  The contribution of collecting duct NOS1 to the concentrating mechanisms in male and female mice.

Authors:  Luciano D Mendoza; Kelly A Hyndman
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

5.  Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

Authors:  Ffolliott M Fisher; Patricia C Chui; Imad A Nasser; Yury Popov; Jeremy C Cunniff; Thomas Lundasen; Alexei Kharitonenkov; Detlef Schuppan; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2014-07-30       Impact factor: 22.682

6.  Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2016-02-17       Impact factor: 2.370

7.  Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.

Authors:  Yanli Cheng; Jingjing Zhang; Weiying Guo; Fengsheng Li; Weixia Sun; Jing Chen; Chi Zhang; Xuemian Lu; Yi Tan; Wenke Feng; Yaowen Fu; Gilbert C Liu; Zhonggao Xu; Lu Cai
Journal:  Free Radic Biol Med       Date:  2016-02-02       Impact factor: 7.376

8.  FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism.

Authors:  Cristal M Hill; Thomas Laeger; Madeleine Dehner; Diana C Albarado; Blaise Clarke; Desiree Wanders; Susan J Burke; J Jason Collier; Emily Qualls-Creekmore; Samantha M Solon-Biet; Stephen J Simpson; Hans-Rudolf Berthoud; Heike Münzberg; Christopher D Morrison
Journal:  Cell Rep       Date:  2019-06-04       Impact factor: 9.423

9.  Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial.

Authors:  Amir Tirosh; Rachel Golan; Ilana Harman-Boehm; Yaakov Henkin; Dan Schwarzfuchs; Assaf Rudich; Julia Kovsan; Georg M Fiedler; Matthias Blüher; Michael Stumvoll; Joachim Thiery; Meir J Stampfer; Iris Shai
Journal:  Diabetes Care       Date:  2013-05-20       Impact factor: 19.112

10.  Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation.

Authors:  Chi Zhang; Minglong Shao; Hong Yang; Liangmiao Chen; Lechu Yu; Weitao Cong; Haishan Tian; Fangfang Zhang; Peng Cheng; Litai Jin; Yi Tan; Xiaokun Li; Lu Cai; Xuemian Lu
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more
  2 in total

Review 1.  Role of circulating molecules in age-related cardiovascular and metabolic disorders.

Authors:  Yung Ting Hsiao; Ippei Shimizu; Yohko Yoshida; Tohru Minamino
Journal:  Inflamm Regen       Date:  2022-01-10

2.  FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice.

Authors:  Cristal M Hill; Diana C Albarado; Lucia G Coco; Redin A Spann; Md Shahjalal Khan; Emily Qualls-Creekmore; David H Burk; Susan J Burke; J Jason Collier; Sangho Yu; David H McDougal; Hans-Rudolf Berthoud; Heike Münzberg; Andrzej Bartke; Christopher D Morrison
Journal:  Nat Commun       Date:  2022-04-07       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.